Director of Oncology Network — Interim, Cancer Care

The mandate

The network director role is vacant, leaving modality and referral decisions fragmented across sites.

The interim must be in place within fourteen days for a seven-month stabilisation. A permanent clinical-network director is being recruited concurrently, with the final month reserved for joint tumour-board and workforce handover.

The assignment is complete when ninety per cent of priority patients begin treatment inside protocol timelines, all modalities have twelve-week consultant coverage, referral leakage returns below eight per cent, and the successor accepts a funded specialty recruitment plan.

The director may reallocate sessions, commission approved visiting consultants and rebalance cases among sites inside a ₹1.2 crore contingency. New radiotherapy capital, permanent physician terms and closure of a modality require executive approval; clinical treatment decisions remain with credentialed practitioners.

The scope does not include redesign of chemotherapy procurement, construction of a planned radiotherapy bunker or marketing beyond referrer recovery. These activities should receive operational input but retain their existing owners.

Why this seat is open

A concentrated specialist exit exposed weak network-level succession and cross-site cover. Patient-access deterioration is too immediate to await a conventional recruitment cycle. The chief clinical officer wants temporary leadership to restore confidence while appointing a director who can own longer-term academic and service development.

What you will own

• Map consultant and modality capacity for the next twelve weeks and close every uncovered high-risk treatment window.
• Decide cross-site case allocation using clinical acuity, equipment availability, travel burden and protocol timing.
• Reinstate multidisciplinary tumour boards with attendance, decision and exception records for each major disease group.
• Negotiate time-limited visiting-consultant cover within approved rates and credentialing requirements.
• Recover referring clinicians through case updates, access commitments and transparent escalation routes rather than incentives.
• Build a funded permanent-workforce plan by specialty, seniority, geography and succession exposure.
• Transfer capacity tools, referrer risks and live clinician searches to the incoming network director during a structured month.

Candidate qualifications

• Medical specialist or hospital executive with eighteen-plus years in oncology delivery and multi-site service leadership.
• Detailed understanding of medical, surgical and radiation oncology dependencies, including physics and specialist nursing capacity.
• Record of stabilising clinician coverage after attrition without compromising credentialing or overloading remaining teams.
• Experience operating multidisciplinary tumour boards and monitoring treatment-start access against clinical protocols.
• Strong standing with oncology referrers, paired with disciplined avoidance of inducement-based growth practices.
• Workforce-planning capability covering visiting arrangements, permanent recruitment and single-specialist succession risk.